This open-label , multicenter , randomized controlled trial included asymptomatic singleton pregnancies from 20 ( +0 ) through 31 ( +6 ) weeks of gestation with a cervical length less than 25 mm and a history of preterm delivery or cervical surgery or uterine malformation or prenatal DES exposure .